MTRY
Income statement / Annual
Last year (2022), Monterey Bio Acquisition Corporation's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Monterey Bio Acquisition Corporation's net income was -$1.27 M.
See Monterey Bio Acquisition Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$2.04 M
|
$0.00
|
$0.00
|
| Gross Profit |
-$2.04 M
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$522,882.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$2,039.00
|
$522,882.00
|
$2.40
|
| Other Expenses |
$2.04 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$2.04 M
|
$522,882.00
|
$2.40
|
| Cost And Expenses |
$2.04 M
|
$522,882.00
|
$2.40
|
| Interest Income |
$881.09
|
$2,371.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$228,485.00
|
$62,716.00
|
$206,297.00
|
| EBITDA |
-$2.04 M |
-$522,882.00 |
$0.00 |
| EBITDA Ratio |
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$881,092.00
|
-$60,345.00
|
$0.00
|
| Income Before Tax |
-$1.16 M
|
-$583,227.00
|
-$2.40
|
| Income Before Tax Ratio |
0
|
0
|
0
|
| Income Tax Expense |
$115,963.00
|
-$2,371.00
|
$0.00
|
| Net Income |
-$1.27 M
|
-$580,856.00
|
-$2.40
|
| Net Income Ratio |
0
|
0
|
0
|
| EPS |
-0.44 |
-0.11 |
-0.001 |
| EPS Diluted |
-0.44 |
-0.11 |
-0.001 |
| Weighted Average Shares Out |
$2.88 M
|
$5.36 M
|
$2,500.00
|
| Weighted Average Shares Out Diluted |
$2.88 M
|
$5.36 M
|
$2,500.00
|
| Link |
|
|
|
